HelioslowFoxp3+ Treg cells are enriched both in peripheral blood and at the tumor site (Figure 2B), but only HelioshiFoxp3+ Treg cells accumulate significantly and specifically in tumors (Figure 2C) and produce IL-17 during CRC. This evidence concerns the gene IL17A and neoplasm.